Rafael Holdings Inc
NYSE:RFL
Rafael Holdings Inc
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 23 full-time employees. The company went IPO on 2018-03-12. The firm operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings, including a building at 520 Broad Street in Newark, New Jersey that houses headquarters for the Company and certain affiliates and its associated public garage and a portion of an office building in Israel.
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 23 full-time employees. The company went IPO on 2018-03-12. The firm operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings, including a building at 520 Broad Street in Newark, New Jersey that houses headquarters for the Company and certain affiliates and its associated public garage and a portion of an office building in Israel.
